Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas

Clinical Cancer Research

Volumn 11, Issue 9, 2005, Pages 3225-3232

  Ueda, Masatsugu ^a   Hung, Yao Ching ^b   Terai, Yoshito ^a   Kanda, Koji ^a   Kanemura, Masanori ^a   Futakuchi, Hikari ^a   Yamaguchi, Hiroyuki ^a   Akise, Daisuke ^a   Yasuda, Masayuki ^a   Ueki, Minoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GELATINASE A; VASCULOTROPIN ANTIBODY; VASCULOTROPIN C;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; OVARY CARCINOMA; PARAAORTIC LYMPH NODE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ANTIBODIES; ANTIGENS, CD34; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PHENOTYPE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 20944436359     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1148     Document Type: Article

References (44)

1. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63.
2. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991;47:219-23.
3. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multiple spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 1995;92:768-72.
4. Kandel J, Bassy-Wetzel E, Radvanyi F, Klagsburn M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of b-FGF in the multistep development of fibrosarcoma. Cell 1991;66: 1095-104.
5. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, Nagura H. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 1993;68:520-7.
6. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S. Angiogenic factor. Nature (Lond) 1992; 356:668.
7. Haraguchi M, Miyadera K, Uemura K, et al. Angiogenic activity of enzymes. Nature (Lond) 1994; 368:198.
8. Moghaddam A, Zhang HT, Fan TPD, et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A 1995;92:998-1002.
9. Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 1996;93: 2576-81.
10. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinase. EMBO J 1996;15:290-8.
11. Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A 1998;95: 548-53.
12. Jetsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (Washington DC) 1997;276:1423-5.
13. Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999;5:1823-9.
14. Valtola R, Salven P, Heikkila P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999;154:1381-90.
15. Bunone G, Vigneri P, Mariani L, et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 1999;155:1967-76.
16. Ueda M, Terai Y, Yamashita Y, et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer 2002;98:335-43.
17. VanTrappen PO, Ryan A, Carroll M, et al. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer 2002;87:537-44.
18. Yamada T, Ueda M, Otsuki Y, Ueki M, Sugimoto O. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol Oncol 1991;40: 118-28.
19. Kiyozuka Y, Ito K, Nakano S, et al. Antiproliferative actions of medroxy-progesterone acetate (MPA) to human ovarian cancer cell lines in vitro. Acta Obstet Gynaecol Jpn 1992;44:137-44.
20. Nozawa S, Tsukazaki K, Sakayori M, Jeng CH, Iizuka R. Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning-with special reference to the stem cell of the tumor. Hum Cell 1988;1:426-35.
21. Nozawa S, Yajima M, Sasaki H, et al, A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II). Jpn J Cancer Res 1991;82:854-61.
22. Tsuji Y, Suzuki T, Nishiura H, Takemura T, Isojima S. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies. Cancer Res 1985;45:2358-62.
23. Suzuki N, Oiwa Y, Sugano I, et al. Dipyridamole enhances an anti-proliferative effect of interferon in various types of human tumor cells. Int J Cancer 1992;51:627-33.
24. Ishiwata I, Ishiwata C, Soma M, Ishikawa H. Establishment of HUOCA-II, a human ovarian clear cell adenocarcinoma cell line, and its angiogenic activity. J Natl Cancer Inst 1987;78:667-73.
25. Ishiwata I, Ishiwata C, Soma M, Nozawa S, Ishikawa H. Characterization of newly established human ovarian carcinoma cell line-special reference of the effects of cis-platinum on cellular proliferation and release of CA125. Gynecol Oricol 1987;26:340-54.
26. Ishiwata I, Ishiwata C, Soma M, Ishikawa H. Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component). Gynecol Oncol 1986;25: 95-107.
27. 3 on vascular endothelial cells. J Cell Physiol 2001;188: 394-402.
28. Yamada Y, Kuroiwa T, Nakagawa T, et al. Transcriptional expression of surviving and its splice variants in brain tumors in humans. J Neurosurg 2003;99: 738-45.
29. Weich HA, Bando H, Brokelmann M, et al. Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA. J Immunol Methods 2004;285:145-55.
30. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-45.
31. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerizod substrates. Anal Biochem 1980;102:196-202.
32. Ueda M, Gemmill RM, West J, et al. Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 2001;85:64-8.
33. Ueda M, Ueki M, Terai Y, et al. Stimulatory effects of EGF and TGF-α on invasive activity and 5′-deoxy-5-fluorouridine sensitivity in uterine cervical-carcinoma SKG-IIIb cells. Int J Cancer 1997;72:1027-33.
34. International Federation of Gynecology and Obstetrics Cancer Committee: staging announcement. Gynecol Oncol 1986;25:383-5.
35. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
36. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002;611: 1315-20.
37. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119: 493-501.
38. Ueda M, Ueki K, Kumagai K, et al. Apoptosis and tumor angiogenesis in cervical cancer after preoperative chemotherapy. Cancer Res 1998;58:2343-6.
39. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
40. Ueda M, Terai Y, Kumagai K, Ueki K, Kanemura M, Ueki M. Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells. Int J Cancer 2001;91: 778-82.
41. Ueda M, Terai Y, Kumagai K, et al. Vascular endothelial growth factor-C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol 2001;82:162-6.
42. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994;79:185-8.
43. Joukov V, Sorsa T, Kumar V, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 1997;16:3898-911.
44. Lu C, Tanigawa N. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res 1997;57:221-4.